These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 19933539)
1. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia. Welsby IJ; Um J; Milano CA; Ortel TL; Arepally G Anesth Analg; 2010 Jan; 110(1):30-5. PubMed ID: 19933539 [TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387 [TBL] [Abstract][Full Text] [Related]
3. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061 [TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. Kuitunen A; Suojaranta-Ylinen R; Raivio P; Kukkonen S; Lassila R J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474 [TBL] [Abstract][Full Text] [Related]
5. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes. Kress DC; Aronson S; McDonald ML; Malik MI; Divgi AB; Tector AJ; Downey FX; Anderson AJ; Stone M; Clancy C Ann Thorac Surg; 2007 May; 83(5):1737-43. PubMed ID: 17462391 [TBL] [Abstract][Full Text] [Related]
6. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Demma LJ; Winkler AM; Levy JH Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317 [TBL] [Abstract][Full Text] [Related]
7. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost. Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117 [TBL] [Abstract][Full Text] [Related]
8. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]
9. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia. Zucker MJ; Sabnani I; Baran DA; Balasubramanian S; Camacho M J Heart Lung Transplant; 2010 Jan; 29(1):53-60. PubMed ID: 19819167 [TBL] [Abstract][Full Text] [Related]
10. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost. Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367 [TBL] [Abstract][Full Text] [Related]
11. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Gettings EM; Brush KA; Van Cott EM; Hurford WE Crit Care; 2006; 10(6):R161. PubMed ID: 17109753 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993 [TBL] [Abstract][Full Text] [Related]
13. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test. Dellaria SM; Greilich PE; Sarode R Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011 [TBL] [Abstract][Full Text] [Related]
14. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Levy JH; Tanaka KA; Hursting MJ Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208 [TBL] [Abstract][Full Text] [Related]
15. Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature. Jaben EA; Torloni AS; Pruthi RK; Winters JL J Clin Apher; 2011; 26(4):219-24. PubMed ID: 21506142 [TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844 [TBL] [Abstract][Full Text] [Related]
17. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population. Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010 [TBL] [Abstract][Full Text] [Related]
18. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II]. Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523 [TBL] [Abstract][Full Text] [Related]